BioSpace News Archive

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative “Complete Vaccine” to fight SARS-CoV-2, announces today that its subsidiary NuGenHealth has signed a contract with Florida Health Care Associates (FHCA)

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis guided management of acute decompensated heart failure (ADHF) utilizing the BVA-100 blood test

Marrone Bio Innovations, Inc., an international leader in sustainable agricultural biological solutions, announced that BIOSt Nematicide seed treatment product, achieved an outstanding climate impact score of 9.8 out of 10.

Asieris Pharmaceuticals (“Asieris”) and BeiGene, Ltd. (“BeiGene”) today announced that they have entered into a clinical collaboration agreement to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab as neoadjuvant therapy in patients with muscle invasive bladder cancer (MIBC)

Lyndra Therapeutics, a clinical-stage biotechnology company working to make daily pills a thing of the past, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for LYN-014, the Company’s oral, ultra-long-acting, extended-release (ER) levomethadone capsule in development for the weekly treatment of opioid use disorde

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on womens intimate health, today announced that it will report its first quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 13, 2021.

PPD, Inc. was named “Best Contract Research Organization” at the 14th annual Vaccine Industry Excellence Awards during the 2021 World Vaccine Congress.

Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced they have entered into a definitive business combination agreement.

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period ended March 31, 2021.

The street team is part of a unique shared investment initiative with six of the region’s leading health organizations